GSTM1 and anemia: In most cases anemia was mild (defined as Hb >10 g/dL according to the National Comprehensive Cancer Network guidelines [2]), but Hb values lower than 10 g/dL were detected in 10% of patients at baseline and in 39.9% of patients during the follow-up.